California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high.

Barclays analyst Andrew Mok CFA maintained a Buy rating on CVS Health (CVS – Research Report) today and set a price target of $73.00. The ...

In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Tenet Healthcare (THC – Research Report), with a price ...

CVS Health Corporation (NYSE:CVS) is a retailer that operates in four segments: health care benefits, health services, ...

The Dow Jones index dropped 400 points on Wednesday, February 12 as US Inflation data dimmed Federal Reserve rate cuts hopes ...

US stocks finished mostly lower on Wednesday after an unexpected acceleration in core inflation spooked markets, causing bond ...

It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain.

Just as Andrew Witty of UnitedHealth Group did in a call with investors last month, CVS Health’s CEO David Joyner defended ...

CVS Health CVS turned in solid fourth-quarter results, and its 2025 guidance for 6%-11% adjusted EPS growth without any share ...

If you’re in the market for a Medicare Advantage plan, you might consider Blue Cross Blue Shield Medicare Advantage and ...

UnitedHealthcare offers a variety of Medicare Advantage plans with a wide range of benefits, often with $0 premiums, copays ...